Adaptive Share Price

Adaptive Share Price

NASDAQ: ADPT | Mid Cap | Healthcare
$28.50
+$0.02 (0.07%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Adaptive Stock Performance

Open
$28.53
Prev. Close
$28.48
Circuit Range
N/A
Day Range
$28.02 - $29.04
Year Range
$12.01 - $32.00
Volume
51,167
Average Traded
$28.50

Adaptive Share Price Today

As of 19 November 2026, Adaptive Biotechnologies Corporation's share price is $28.50. The stock opened at $28.53, compared to its previous close of $28.48. During today's trading session, Adaptive Biotechnologies Corporation's share price traded between $28.02 and $29.04, with an average price of $28.53. Over the past 52 weeks, the stock has recorded a high of $32.00 and a low of $12.01. In terms of performance, Adaptive Biotechnologies Corporation's share price has risen by 88.12% over the last six months and is up 44.96% on a year-on-year basis.

Adaptive Share Price Chart

Line chart of the Adaptive price trend over the selected period. The price rose overall, ranging from 28.02 to 29.17, ending at 28.50.
$28.02$29.04
L
Show Current Price
H

Adaptive Stock Fundamentals & Key Indicators

Market Cap
$4.32B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.44
Revenue (TTM)
$276.98B
Return On Equity (TTM)
-40.06%
Profit Margin
-21.48%
Debt to Equity
1.90
Quarterly Earnings Growth YoY
120.69%

Adaptive Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$71.68$70.87$71.55$83.90
Net Profit-$13.58-$20.03-$39.79$2.81
Net Profit Margin-18.95%-28.26%-55.61%3.35%
Income ChangeN/A-47.50%-98.65%107.06%

Adaptive Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$185.31$170.28$178.96$276.98
Net Profit-$200.19-$225.25-$159.49-$59.50
Net Profit Margin-108.03%-132.28%-89.12%-21.48%
Income ChangeN/A-12.52%29.19%62.69%

Adaptive Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets212.55255.62250.95294.47
Current Assets300.19283.75410.19562.15
Total Assets512.74539.38661.13856.62
Non Current Liabilities197.82238.84264.84282.73
Current Liabilities89.9298.0588.02109.79
Total Liabilities287.74336.89352.86392.52
Shareholders' Equity225.0202.49308.28464.1

Adaptive Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-45.99-95.21-156.32-183.95
Investing37.9577.79129.652.91
Financing30.40.242.25132.27

About Adaptive

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Adaptive Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$26.89
$28.48
+7.03%
Oct 2026
$28.82
$26.61
-8.02%
Sep 2026
$24.93
$28.93
+9.48%
Aug 2026
$22.88
$26.43
+17.10%
Jul 2026
$21.46
$22.57
+5.32%
Jun 2026
$14.97
$21.43
+41.45%
May 2026
$14.34
$15.15
+7.48%
Apr 2026
$14.09
$14.10
+1.51%
Mar 2026
$15.74
$13.88
-13.44%
Feb 2026
$18.36
$16.04
-13.30%
Jan 2026
$16.27
$18.50
+13.95%
Dec 2025
$19.28
$16.23
-17.42%

Adaptive Share Price FAQs